<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01170494</url>
  </required_header>
  <id_info>
    <org_study_id>RAC 2101041</org_study_id>
    <nct_id>NCT01170494</nct_id>
  </id_info>
  <brief_title>Effect of Vitamin D Oral Supplements on 25 OH Vitamin D Levels</brief_title>
  <official_title>Effect of Vitamin D Oral Supplements on 25 OH Vitamin D Levels: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Faisal Specialist Hospital &amp; Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King Faisal Specialist Hospital &amp; Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitamin D deficiency is common world wide. 25 OH vitamin D level is the best indicator of
      vitamin D status. Vitamin D supplements are available as vitamin D2 or D3, in small daily or
      large weekly/monthly doses. Controversy continues on the relative potency of vitamin D2
      compared to D3 and of daily compared to weekly or monthly doses, in increasing/maintaining
      total 25 OH vitamin D level.

      The investigators plan to conduct a controlled trial to compare the effect of various vitamin
      D supplements on 25 OH vitamin D levels in healthy adults with starting 25 OH vitamin D level
      between 20 to 50 nmol/L.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>area under the curve of 25 OH vitamin D level</measure>
    <time_frame>140 days</time_frame>
    <description>area under the curve of total 25 OH vitamin D level from day 1 to 140</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cmax of 25 OH vitamin D</measure>
    <time_frame>140 days</time_frame>
    <description>Cmax of total 25 OH vitamin D over the treatment period of 140 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tmax of 25 OH vitamin D level</measure>
    <time_frame>140 days</time_frame>
    <description>Tmax of total 25 OH vitamin D over the treatment period of 140 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>area under the curve of vitamin D level</measure>
    <time_frame>140 days</time_frame>
    <description>area under the curve of total vitamin D level over 140 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of hypercalcemia</measure>
    <time_frame>140 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of hypercalciuria</measure>
    <time_frame>140 days</time_frame>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Actual">279</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>D2 2000 IU daily</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>D3 2000 IU daily</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>D2 1000 IU + D3 1000 IU daily</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>D2 25000 IU Q2wk</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>D3 25000 IU Q2wk</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>D2 50000 IU Q4wk</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>D3 50000 IU Q4wk</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo daily</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ergocalciferol 2000 IU orally, daily</intervention_name>
    <description>ergocalciferol 2000 IU orally, daily</description>
    <arm_group_label>D2 2000 IU daily</arm_group_label>
    <other_name>ergocalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ergocalciferol 25000 IU oraly every 2 weeks</intervention_name>
    <description>ergocalciferol 25000 IU oraly every 2 weeks</description>
    <arm_group_label>D2 25000 IU Q2wk</arm_group_label>
    <other_name>ergocalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ergocalciferol 50000 IU orally every 4 weeks</intervention_name>
    <description>ergocalciferol 50000 IU orally every 4 weeks</description>
    <arm_group_label>D2 50000 IU Q4wk</arm_group_label>
    <other_name>ergocalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ergocal1000 IU &amp; cholecal 1000 IU orally daily</intervention_name>
    <description>ergocalciferol 1000 IU and cholecalciferol 1000 IU orally every day</description>
    <arm_group_label>D2 1000 IU + D3 1000 IU daily</arm_group_label>
    <other_name>ergocalciferol and cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cholecalciferol 2000 IU orally daily</intervention_name>
    <description>cholecalciferol 2000 IU orally everyday</description>
    <arm_group_label>D3 2000 IU daily</arm_group_label>
    <other_name>cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cholecalciferol 25000 IU orally every 2 weeks</intervention_name>
    <description>Cholecalciferol 25000 IU orally every 2 weeks</description>
    <arm_group_label>D3 25000 IU Q2wk</arm_group_label>
    <other_name>Cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cholecalciferol 50000 orally every 4 weeks</intervention_name>
    <description>Cholecalciferol 50000 orally every 4 weeks</description>
    <arm_group_label>D3 50000 IU Q4wk</arm_group_label>
    <other_name>Cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo orally everyday</intervention_name>
    <description>placebo orally everyday</description>
    <arm_group_label>placebo daily</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy adults living in Riyadh area who consume no more than one serving of milk/day,
             do not take vitamin supplement, habitually have less than 10 hr of sun exposure per
             week, don't suffer from granulomatous conditions, liver disease, or kidney disease,
             and don't take anticonvulsants, barbiturates, or steroids.

          -  25 OH vitamin D level between 20 to 50 nmol/L.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Muhammad M Hammami, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>King Faisal Specialist Hospital &amp; Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>King Faisal Specialist Hospital &amp; research Center</name>
      <address>
        <city>Riyadh</city>
        <zip>11211</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 25, 2010</study_first_submitted>
  <study_first_submitted_qc>July 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2010</study_first_posted>
  <last_update_submitted>August 29, 2016</last_update_submitted>
  <last_update_submitted_qc>August 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>King Faisal Specialist Hospital &amp; Research Center</investigator_affiliation>
    <investigator_full_name>Muhammad Maher Hammami</investigator_full_name>
    <investigator_title>Chairman, Department of Clinical Studies &amp; Empirical Ethics</investigator_title>
  </responsible_party>
  <keyword>vitamin D2, vitamin D3, 25 Oh vitamin D2, 25 Oh vitamin D3</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

